Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 136 (1), 7-12

Pathology Consultation on Drug-Induced Hemolytic Anemia

Affiliations

Pathology Consultation on Drug-Induced Hemolytic Anemia

Arand Pierce et al. Am J Clin Pathol.

Abstract

Drug-induced immune hemolytic anemia is considered to be rare but is likely underrecognized. The consulting pathologist plays a critical role in integrating serologic findings with the clinical history, as drug-induced antibodies should be distinguished as either drug-dependent or drug-independent for appropriate clinical management. Drug-dependent antibodies (DDABs) are most commonly associated with cefotetan, ceftriaxone, and piperacillin, whereas fludarabine, methyldopa, β-lactamase inhibitors, and platinum-based chemotherapeutics are frequent causes of drug-independent antibodies (DIABs). DDABs usually demonstrate a positive direct antiglobulin test and a negative elution, while DIABs are serologically indistinguishable from warm autoantibodies and are similarly steroid-responsive. Drug cessation is always recommended.

Similar articles

See all similar articles

Cited by 18 PubMed Central articles

See all "Cited by" articles

MeSH terms

Feedback